PT - JOURNAL ARTICLE AU - KEIICHI ARAKAWA AU - KEISUKE HATA AU - HIROAKI NOZAWA AU - KAZUSHIGE KAWAI AU - TOSHIAKI TANAKA AU - TAKESHI NISHIKAWA AU - KAZUHITO SASAKI AU - YASUTAKA SHUNO AU - MANABU KANEKO AU - MASAYA HIYOSHI AU - SHIGENOBU EMOTO AU - KOJI MURONO AU - HIROFUMI SONODA AU - SOICHIRO ISHIHARA TI - Prognostic Significance and Clinicopathological Features of Synchronous Colorectal Cancer AID - 10.21873/anticanres.12932 DP - 2018 Oct 01 TA - Anticancer Research PG - 5889--5895 VI - 38 IP - 10 4099 - http://ar.iiarjournals.org/content/38/10/5889.short 4100 - http://ar.iiarjournals.org/content/38/10/5889.full SO - Anticancer Res2018 Oct 01; 38 AB - Aim: This study aimed to clarify the difference in the clinicopathological and prognostic features between synchronous colorectal cancer (CRC) and solitary CRC. Materials and Methods: A retrospective analysis was conducted in patients with synchronous and solitary CRC. Results: A total of 92 (7.1%) out of 1,295 consecutive patients had synchronous CRC. Mucinous adenocarcinoma was more frequent in patients with synchronous CRC than in those with solitary CRC (13.0% vs. 3.7%; p<0.001). The 5-year relapse-free survival (RFS) rate was poorer in patients with synchronous CRC than in those with solitary CRC (65.3% vs. 75.1%; p=0.035), which was contrived by the multivariate analysis (hazard ratio=1.52(HR); p=0.039). Conclusion: Patients with synchronous CRC had a poorer RFS than those with solitary CRC; thus, patients with synchronous CRC might require more intensive care than those with solitary CRC in follow-up.